AbbVie officer plans $4.02M sale of 13,481 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AbbVie Inc. officer Azita Saleki-Gerhardt reported an intended sale of 13,481 common shares, with an aggregate market value of $4,024,850.96 and an approximate sale date of November 16, 2026. She acquired the shares from AbbVie through a cash-paid stock option exercise dated November 16, 2026; Morgan Stanley Smith Barney LLC is listed as broker.
Key Figures
Key Terms
Stock Option Exercise technical
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.